A ndropause, also known as late-onset hypogonadism (LOH) or hypogonadism in aging males, is due to alterations in the testicular and hypothalamic-pituitary functions (1). A reduction in both the hormone production by the Leydig cells and in the GnRH secretion by the hypothalamus takes place, leading to inadequate secretion of LH by the pituitary (1). Some elders, however, have normal LH levels in the presence of hypogonadism and its increase is not required for the LOH diagnosis (2). The androgen deficiency in elderly males is normally partial and only a few of them clearly display hormonal levels under the lower limit for young and healthy males, which makes the hypogonadism diagnosis harder in such cases (1).
Clapauch e cols. (4) also evaluated the advantage of three questionnaires as the screening tool for LOH diagnosis: Androgen Defi ciency of the Aging Male, AMS, and International Index of Erectile Function (IIEF-5) (for references, please see 4). However, no important correlation between the total testosterone (TT), calculated free testosterone (cFT) and calculated bioavailable testosterone (cBT) with three questionnaires was found.
Testosterone is a pro-hormone which originates two other hormones that are active in the male metabolism: estradiol (E 2 ) and 5-alpha-dihydrotestosterone (DHT) (7, 8) . It is thus not surprising that no form of testosterone evaluation was related to the questionnaires evaluated by Clapauch e cols. (4), accordingly to all other studies mentioned in the article, which also evaluated circulating testosterone forms, but not its active metabolites (4). Free and bioavailable E 2 levels can decline due to the increase of SHBG (7) and this may jeopardize its benefi cial effect on bone, brain, lipids, and cardiovascular system (7). Nevertheless, a correlation between the E 2 level and AMS scale was not observed (9) . Testosterone is converted by 5-alpha-reductases into DHT which has an important action in sexual activity, sexual characters and brain (8) . The use of transdermal DHT signifi cantly improved sexual function evaluated by IIEF-5 (8), a typical action of the DHT not correlated with the testosterone levels of the study presented by Clapauch e cols. (4) .
The syndrome related to the male aging process, evaluated by the questionnaires, could also be due to factors other than the testosterone level decrease, such as the age-related defi cit of GH and IGF-1, central and peripheral nervous system alterations, inactivity and immobility (1, 2) . On the other hand, the age-related declination of testosterone levels is almost not seen in healthy males, which are those who do not have any chronic disease or who have a healthy lifestyle (5) and a signifi cant number of males remain eugonadic even at advanced ages (6) .
In conclusion, the use of questionnaires used in the study made by Clapauch e cols. (4) for andropause diagnosis is not recommended (1); the diagnosis for androgen defi ciency should only be made in males with consistent testosterone-defi ciency-related symptoms and signs and with an unequivocal decrease of testosterone levels (1,2) ; in addition, hormonal dosage as the screening tool for androgen defi ciency is not recommended in the general population (1) .
